Clinical Trial Detail

NCT ID NCT01490749
Title Trial of XELOX Followed by Radiation Combined With Carboplatin and RAD001 for Esophageal Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Emory University

gastroesophageal junction adenocarcinoma

esophagus adenocarcinoma

esophagus squamous cell carcinoma


Carboplatin + Cetuximab + Everolimus + Paclitaxel

Age Groups: adult

No variant requirements are available.